Sign in or Register
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our milestones
    • Management Team
    • Board of Directors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Partnered Programs in Clinic
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us
Aurigene
Home
  • Home
    • The story of Aurigene
    • The Aurigene approach
    • Our impact
    • Media center
    • Our publications
  • About Us
    • Our journey
    • Our purpose
    • Our milestones
    • Management Team
    • Board of Directors
  • Science
    • Science
      • Our research
      • Our platform technologies
      • Our publications
    • Pipeline
      • Proprietary Pipeline
      • Partnered Programs in Clinic
  • News and Events
    • Aurigene in the media
    • News
    • Events
  • Careers
    • Life at Aurigene
    • Working at Aurigene
    • Perks at Aurigene
    • Teamwork
    • Current Openings
    • A word from Aurigeneans
  • Contact Us

Aurigene and Orion Corporation Announce Research, Collaboration and Option Agreement for Rights to Aurigene’s Epigenetics Program for Pan BET and Selective BET Bromodomain Inhibitors

  1. Home
  2. news-2014
June 25, 2014
by admin-aurigene

Aurigene and Orion Corporation Announce Research, Collaboration and Option Agreement for Rights to Aurigene’s Epigenetics Program for Pan BET and Selective BET Bromodomain Inhibitors

ESPOO, Finland and BANGALORE, India, June 24, 2014 /PRNewswire/ — Orion Corporation, a globally operating Finnish pharmaceuticals company and Aurigene, a leading biotech company based in India, today announced that
Home
  • Pipeline
  • Publications
  • Science
  • News and Events
  • Careers
Careers
Contact Us

Governance

Code of Business Conduct and Ethics

  • Statement of Policy
  • Link to Raise Concerns

Annual Reports

  • Link to View Report

Safety, Health, Environment and Sustainability

  • Policy Statement and Reports

Policies

CSR

  • Statement of Policy
  • Guiding Principles
  • Activities

Remuneration Policy

  • Statement of Policy

© 2022 Aurigene Discovery Technologies

Privacy & GDPR policy

Cookie policy

Crafted by: Pink Lemonade Communications Pvt. Ltd.

© 2022 Aurigene Oncology

Privacy and GDPR Policy

Cookie Policy

Apply Now